Services

Professional and Cost-Saving Solutions

Screening of Random Mutagenesis Enzyme Libraries

At Creative Enzymes, our Screening of Random Mutagenesis Enzyme Libraries Service completes the enzyme engineering cycle by identifying the best-performing mutants from complex, high-diversity libraries. Through precision assay integration, automated high-throughput screening, and intelligent data analysis, we isolate enzyme variants that exhibit the desired catalytic, stability, or selectivity enhancements.

This service transforms vast mutant collections into meaningful functional discoveries. Whether your goal is to improve catalytic efficiency, shift substrate preference, boost thermostability, or enhance solvent tolerance, Creative Enzymes provides a scientifically rigorous, efficient, and reproducible screening solution—customized to your enzyme system and project objectives.

Background: How Library Screening Works

After constructing a mutagenesis library and designing suitable activity assays, the next and most decisive step in directed enzyme evolution is functional screening. This process determines which mutants truly deliver improved performance and ensures that no valuable variant is overlooked.

However, screening can easily become a bottleneck. The size and diversity of mutagenesis libraries often exceed the practical throughput of traditional methods. Many screening campaigns fail because they are limited by assay sensitivity, inconsistent expression, or inefficient data processing.

To overcome these challenges, Creative Enzymes employs integrated high-throughput screening (HTS) platforms and rational screening strategies. Our approach balances coverage, accuracy, and efficiency—ensuring meaningful discovery even in libraries containing millions of variants. Every screening campaign is carefully designed to match the enzyme type, reaction system, and specific project goal, making it both scientifically sound and industrially scalable.

Workflow of protein engineering by directed evolutionFigure 1. Directed evolution of enzymes by iterative cycles of random mutagenesis, protein expression and screening or selection. (Wang et al., 2021)

What We Offer: Mutant Library Screening

Creative Enzymes provides a complete suite of services for mutant library screening, combining molecular biology, assay technology, and data analytics into a single, cohesive workflow. Our offerings include:

Primary Screening of Mutant Libraries

Rapid initial screening to identify variants with detectable or enhanced activity relative to the wild-type enzyme.

Secondary and Tertiary Screening

Verification and quantitative analysis of promising candidates under refined assay conditions.

High-Throughput Screening Platforms

Automated microplate-based, robotic, or droplet microfluidic systems for libraries ranging from 103 to 108 variants.

Multiple Detection Modalities

Fluorescent, colorimetric, luminescent, and chromatographic detection compatible with diverse enzyme reactions.

Tailored Selection Strategies

Screening for activity, selectivity, stability, solvent tolerance, or other user-defined performance parameters.

Kinetic Characterization of Top Variants

Determination of kinetic constants (KM, kcat, Vmax) and performance metrics for selected mutants.

Data Management and Analysis

Comprehensive statistical analysis and ranking of variants, with integration of machine learning-assisted hit identification where appropriate.

Optional Re-screening and Validation

Confirmatory testing under industrially relevant or application-specific conditions.

Scalable Screening Solutions

From small-scale exploratory studies to full industrial-scale discovery campaigns.

Service Workflow

Service workflow of library screening for enhanced enzyme variants

Service Features

Parameter Specification
Library Size Supported 103 – 108 variants
Screening Throughput Up to 105 variants/day (automated platforms)
Detection Formats Colorimetric, fluorescent, luminescent, or analytical (HPLC/GC)
Data Output Ranked activity tables, kinetic values, and diversity analysis
Host Systems E. coli, Pichia pastoris, Bacillus subtilis, yeast, or custom strains
Turnaround Time 4–8 weeks, depending on library scale and complexity
Deliverables Ranked list of improved variants, plasmids/cell stocks, screening report, and validation data

Optional Downstream Support

After successful screening, Creative Enzymes can provide additional services such as protein expression optimization, purification, and biochemical characterization of selected mutants.

Inquiry

Why Partner with Creative Enzymes

Integrated Expertise

We bring together molecular biology, enzymology, and bioanalytics to deliver cohesive, scientifically rigorous screening workflows.

Advanced High-Throughput Platforms

Robotic and microfluidic systems ensure high precision and reproducibility even with large libraries.

Flexible Screening Strategies

Customizable workflows tailored to the desired enzyme property and assay design.

Quantitative and Reproducible Results

All hits validated through statistical and kinetic evaluation, ensuring genuine improvements.

Industrial Relevance

Screening conditions can be adapted to mimic application environments (e.g., solvents, pH, temperature).

Seamless Integration with Prior Modules

Fully compatible with Creative Enzymes' mutagenesis and assay design services for an end-to-end directed evolution pipeline.

Representative Case Studies

Case 1: Discovery of a High-Activity Lipase Variant for Biodiesel Production

Client Need:

An industrial biofuel producer sought a lipase variant capable of higher catalytic efficiency in transesterification reactions using low-cost feedstocks. The native lipase showed suboptimal conversion rates and limited tolerance to methanol.

Our Approach:

Using a 106-member mutagenesis library previously constructed by Creative Enzymes, we performed a two-stage screening campaign. A high-throughput colorimetric assay was first used to rapidly evaluate hydrolysis activity in 384-well plates. Promising clones were then subjected to a secondary screening under methanol-rich conditions to assess solvent tolerance and conversion efficiency.

Outcome:

Out of one million screened variants, 47 mutants exhibited enhanced hydrolysis activity, and 6 maintained strong performance in methanol. The top lipase variant demonstrated a 4.3-fold increase in catalytic efficiency and retained 85% of its activity after exposure to 20% methanol—significantly improving biodiesel yield in pilot-scale reactions.

Case 2: Identification of Thermostable Protease Variants for Food Processing

Client Need:

A food technology company required a protease capable of maintaining activity at elevated processing temperatures (70–80°C) without losing specificity or causing undesired side reactions.

Our Approach:

We employed an integrated fluorescence-based screening platform. We used a temperature-controlled microplate reader to assess protease activity across 104 mutants at increasing temperatures. Initial hits were rescreened to confirm reproducibility and to measure residual activity after thermal incubation.

Outcome:

We identified multiple mutants with substantially improved thermostability. The top protease variant retained 90% of its activity after one hour at 75°C, compared to 30% for the wild type. The enzyme's catalytic parameters (kcat/KM) improved by 2.5-fold, enabling more efficient protein hydrolysis during high-temperature food processing and extending product shelf life.

Common Questions About Mutant Library Screening

  • Q: What library sizes can you screen?

    A: We can handle libraries ranging from a few thousand to over 100 million variants, depending on assay format and screening platform.
  • Q: What detection methods are available?

    A: We offer multiple detection modalities including absorbance, fluorescence, luminescence, and chromatographic analysis (HPLC/GC). We choose the most appropriate method based on the enzyme class and target reaction.
  • Q: How do you ensure reliable identification of hits?

    A: All assays are validated for reproducibility, and hit selection is guided by statistical thresholds (e.g., >3σ above wild-type activity). Promising variants are re-screened for confirmation.
  • Q: Can you screen for properties other than catalytic activity?

    A: Yes. We can design customized screening strategies for thermostability, solvent tolerance, pH stability, or enantioselectivity.
  • Q: How is data from large-scale screens managed?

    A: Data are processed using automated pipelines and analyzed statistically to ensure accurate normalization and ranking. Detailed reports include both raw and processed data.
  • Q: Do you provide isolated mutant clones?

    A: Yes. We can supply plasmids, glycerol stocks, or purified enzymes for further analysis or scale-up.
  • Q: Are your screening conditions customizable?

    A: Absolutely. Screening conditions—such as temperature, solvent composition, or substrate concentration—can be tailored to reflect your application environment.
  • Q: Can your service be combined with assay development or mutagenesis?

    A: Yes. Our screening service is fully integrated with mutagenesis library construction and activity assay design services, enabling a seamless end-to-end workflow from variant generation to hit discovery.
  • Q: What is the typical project timeline?

    A: Most screening projects are completed within 4–8 weeks, depending on library complexity, throughput, and validation steps required.
  • Q: How do you protect client confidentiality and intellectual property?

    A: All project data, sequences, and results are handled under strict confidentiality. Intellectual property and ownership of all variants and data remain with the client.

Reference:

  1. Wang W, Taber DF, Renata H. Practical enzymatic production of carbocycles. Chemistry A European J. 2021;27(46):11773-11794. doi:10.1002/chem.202101232

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.